CVS Health Corporation $CVS Shares Newly Purchased by One Way Holdings LLC

One Way Holdings LLC acquired a new position in shares of CVS Health Corporation (NYSE:CVS) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 121,662 shares of the pharmacy operator’s stock, valued at approximately $10,425,000.

Several other institutional investors and hedge funds also recently made changes to their positions in CVS. Handelsbanken Fonder AB raised its stake in shares of CVS Health by 83.6% in the second quarter. Handelsbanken Fonder AB now owns 1,089,694 shares of the pharmacy operator’s stock worth $112,729,000 after purchasing an additional 496,124 shares during the last quarter. BNP Paribas boosted its position in CVS Health by 105.2% during the 2nd quarter. BNP Paribas now owns 49,971 shares of the pharmacy operator’s stock valued at $5,154,000 after buying an additional 25,617 shares during the period. Nykredit A S bought a new position in CVS Health in the 2nd quarter worth $209,813,000. Bank of America Corp DE grew its position in shares of CVS Health by 148.0% in the 2nd quarter. Bank of America Corp DE now owns 23,188,670 shares of the pharmacy operator’s stock worth $2,398,868,000 after buying an additional 13,836,701 shares during the period. Finally, Oppenheimer Asset Management Inc. purchased a new position in CVS Health in the second quarter worth about $49,622,000. Institutional investors and hedge funds own 80.66% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on CVS. Barclays boosted their price objective on shares of CVS Health from $106.00 to $108.00 and gave the company an “overweight” rating in a research report on Thursday, August 6th. Robert W. Baird set a $107.00 price objective on CVS Health in a report on Thursday, August 6th. HSBC restated a “hold” rating and issued a $103.00 price target on shares of CVS Health in a research report on Monday, July 6th. JPMorgan Chase & Co. upped their price target on shares of CVS Health from $111.00 to $118.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 12th. Finally, UBS Group restated a “buy” rating on shares of CVS Health in a research note on Tuesday, September 22nd. Nineteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $109.64.

CVS Health Trading Down 0.1%

CVS opened at $90.20 on Monday. The business’s 50 day moving average price is $91.22 and its 200 day moving average price is $88.76. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.66 and a current ratio of 0.87. The stock has a market capitalization of $115.36 billion, a PE ratio of 23.86, a P/E/G ratio of 0.84 and a beta of 0.58. CVS Health Corporation has a one year low of $69.51 and a one year high of $110.68.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 EPS for the quarter, topping analysts’ consensus estimates of $1.87 by $0.71. CVS Health had a return on equity of 13.12% and a net margin of 1.18%. The company had revenue of $106.10 billion for the quarter, compared to analysts’ expectations of $100.03 billion. During the same period in the prior year, the firm earned $1.81 earnings per share. The firm’s revenue was up 7.3% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. As a group, equities research analysts expect that CVS Health Corporation will post 8.02 EPS for the current year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, November 2nd. Investors of record on Thursday, October 22nd will be paid a $0.6650 dividend. The ex-dividend date is Thursday, October 22nd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 2.9%. CVS Health’s payout ratio is 70.37%.

CVS Health Company Profile

CVS Health Corporation (NYSE: CVS) is a diversified health care company that provides pharmacy, insurance and health services in the United States. Its businesses serve consumers, employers, health plans and health care providers through pharmacies, benefit programs, insurance coverage and clinical care services.

The company’s Pharmacy Services segment, led by CVS Caremark, manages prescription drug benefits for employers, insurers and government programs. CVS Pharmacy operates retail pharmacies and health-focused stores that dispense prescriptions and offer over-the-counter products, health and wellness merchandise, immunizations and related services.